After working with biotechs and Big Pharmas to accelerate its research programs, the high-tech molecule modeler Schrödinger is taking its first steps as a clinical company itself. | After working with biotechs and Big Pharmas to accelerate their research programs, the high-tech molecule modeler Schrödinger is taking its first steps as a clinical company.
Source: Schrödinger plots first human trial of AI-designed cancer drug | Fierce Biotech
